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Protein homeostasisMitochondria are compartmentalized organelles essential for numerous cellular functions including ATP gen-
eration, iron-sulfur cluster biogenesis, nucleotide and amino acid metabolism as well as apoptosis. To pro-
mote biogenesis and proper function, mitochondria have a dedicated repertoire of molecular chaperones to
facilitate protein folding and quality control proteases to degrade those proteins that fail to fold correctly. Mi-
tochondrial protein folding is challenged by the complex organelle architecture, the deleterious effects of
electron transport chain-generated reactive oxygen species and the mitochondrial genome's susceptibility
to acquiring mutations. In response to the accumulation of unfolded or misfolded proteins beyond the orga-
nelle's chaperone capacity, cells mount a mitochondrial unfolded protein response (UPRmt). The UPRmt is a
mitochondria-to-nuclear signal transduction pathway resulting in the induction of mitochondrial protective
genes including mitochondrial molecular chaperones and proteases to re-establish protein homeostasis
within the mitochondrial protein-folding environment. Here, we review the current understanding of
UPRmt signal transduction and the impact of the UPRmt on diseased cells. This article is part of a Special
Issue entitled: Protein Import and Quality Control in Mitochondria and Plastids.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Mitochondrial protein homeostasis is maintained through proper
folding and assembly of newly translated polypeptides, as well as
efﬁcient trafﬁcking and turnover of those proteins that fail to fold
correctly [1–3]. The load of unfolded proteins in mitochondria
must precisely match the chaperone protein-folding capacity. If the
chaperone capacity is exceeded, each organelle becomes susceptible
to the deleterious effects of protein misfolding and aggregation.
However, during stress cells employ strategies to protect the
protein-folding environment including organelle-speciﬁc quality
control proteases to degrade the unfolded or misfolded proteins
[4] and mitochondrial unfolded protein responses to increase chap-
erone capacity and re-establish homeostasis within the mitochon-
drial protein-folding environment [5]. Several factors challenge the
mitochondrial protein-folding environment including complexities
in mitochondrial biogenesis, DNA and protein damaging reactive ox-
ygen species (ROS) that are generated within mitochondria, as well
as environmental factors such as changes in temperature and expo-
sure to toxins [6].Import and Quality Control in
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l rights reserved.1.1. Complexities of mitochondrial biogenesis that threaten
protein homeostasis
Mitochondria are double-membrane bound organelles composed
of four compartments: the outer and inner membranes, the inter-
membrane space (IMS) and the matrix. Each compartment is a sepa-
rate protein-folding environment, which must be maintained for
efﬁcient mitochondrial biogenesis and proper function. The mito-
chondrial proteome is composed of approximately 1200 proteins
encoded by two separate genomes [7]. The mitochondrial genomes
(mtDNA) are localized within the matrix and encode 13 essential
components of the electron transport chain (ETC) and the ATP
synthase as well as a number of mitochondrial-speciﬁc tRNAs. The re-
mainder of the mitochondrial proteome is encoded by the nuclear
genome, translated in the cytosol and imported into each mitochon-
drion [8,9]. Because ETC complexes I, III, IV and the ATP synthase
are composed of components encoded by both genomes, it is imper-
ative that expression from both genomes be coordinated to prevent
the accumulation of orphaned subunits.
The mitochondrial protein-folding environment can be disturbed
by excessive ROS generated from the ETC primarily via the NADH-
ubiquinone oxidoreductase (complex I) and the ubiquinol cyto-
chrome c oxidoreductase (complex III) [10,11], which directly per-
turb protein folding and structure. Additionally, mtDNA is prone to
the accumulation of mutations, presumably because of its exposure
to ROS and that it is not protected by histones [12,13]. Mutations
that reduce expression of ETC components or perturb their ability to
fold, compromise assembly of the individual complexes putting stress
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impair protein homeostasis such as paraquat, which causes high
levels of ROS accumulation [14], and rotenone, which impairs com-
plex I assembly and function [15].
1.2. Mitochondrial protein quality control: chaperones and proteases
To promote efﬁcient mitochondrial protein folding and complex
assembly, mitochondria have a dedicated repertoire of localized mo-
lecular chaperones located in both the IMS and matrix [1,9]. The
Hsp60 chaperonin is in the matrix and consists of both Hsp60 and
Hsp10 subunits which form a barrel-shaped complex. Hsp60 primar-
ily facilitates the folding of relatively small, soluble monomeric pro-
teins [16–18]. mtHsp70 also resides in the matrix where it performs
multiple functions. At the translocase of the inner membrane
(TIM23) channel, mtHsp70 functions in the multi-subunit PAM (Pre-
sequence Translocase-Associated Motor) where it interacts with the
translocating polypeptides to drive their movement through the im-
port channel into the matrix [9,19]. In a separate complex, mtHsp70
promotes protein folding and complex assembly of imported poly-
peptides while preventing aggregation [20–22]. Additionally,
mtHsp70 is required for the biogenesis of iron–sulfur clusters within
the matrix [23]. Mitochondria also contain an Hsp90 isoform known
as TRAP-1 (TNF receptor-associated protein 1) that is thought to pro-
mote protein folding in a manner similar to the cytosolic isoforms of
Hsp90 [24]. At present, no member of the Hsp60 or Hsp70 family of
molecular chaperones has been observed in the IMS of mitochondria,
however the Tim9-Tim10 complex promotes the import of highly hy-
drophobic membrane spanning proteins by preventing non-
productive protein–protein interactions as the polypeptides traverse
the IMS [25].
In addition to molecular chaperones, mitochondria house several
quality control proteases that recognize and degrade those proteins
that fail to fold or assemble correctly. Both ClpXP and Lon are AAA
proteases (ATPase Associated with diverse cellular Activities) located
within the matrix that primarily degrade misfolded soluble proteins
[3,4]. Interestingly, the Lon protease has been shown to preferentially
degrade oxidatively-damaged proteins including aconitase [26]. Both
Paraplegin (encoded by the SPG7 gene) and YME1L are AAA proteases
that are anchored within the inner membrane with their active sites
facing the matrix and IMS, respectively. The primary role of YME1L
and Paraplegin is to degrade misfolded or misassembled subunits of
the ETC [27], although a recent role has been described for Paraplegin
in mitochondrial ribosome biogenesis [28,29]. OMI/Htra2 resides in
the IMS where it has been suggested to recognize and degrade soluble
proteins that fail to fold correctly [30].
Numerous disease scenarios in which mitochondrial protein ho-
meostasis is compromised emphasize the importance of maintaining
the mitochondrial protein-folding environment [13,31,32]. Both para-
quat and rotenone, as well as the Htra2-deletion cause Parkinson's-
like symptoms in mice [15,33]. Mutations in the mitochondrial cha-
peronin Hsp60 and mitochondrial quality control protease Paraplegin
cause the neurodegenerative disease spastic paraplegia [34]. In addi-
tion to a variety of diseases, loss of mitochondrial protein homeostasis
has been closely associated with the aging process [6,13].
2. Compartment-speciﬁc unfolded protein response pathways
The cytosol, endoplasmic reticulum and mitochondria are all ex-
posed to nascent polypeptides, thus each compartment requires
dedicated protein-folding machinery, which constitutes each orga-
nelle's protein-folding capacity. Stress occurs when the quantity of
unfolded or misfolded proteins exceeds a compartment's protein-
folding capacity, rendering the organelle susceptible to catastrophic
damage. To adjust folding capacity, eukaryotic cells have evolvedorganelle-speciﬁc signaling pathways known as unfolded protein re-
sponses (UPRs).
The heat shock response protects the cytosolic protein-folding
environment and is regulated by the transcription factor Heat
Shock Factor 1 (HSF1) [35]. In the absence of stress, HSF1 associates
with the cytosolic chaperones Hsp70 and Hsp90. However, when
unfolded proteins accumulate beyond the cytosolic chaperone ca-
pacity, HSF1 dissociates allowing it to trimerize and interact with
the promoters of genes that constitute the heat shock response
[36]. HSF1 mediates the expression of a number of chaperone
genes that localize to the cytosol and nucleus including Hsp70
and Hsp90. Additionally, HSF1 induces the expression of a number
of components of the ubiquitin-proteasome system to degrade ter-
minally misfolded proteins and reduce the burden on the cytosolic
protein-folding machinery [36]. Conditions that activate the heat
shock response include increased temperatures and exposure to
toxins such as arsenite that perturb protein folding in the cytosol
[37,38].
The protein-folding environment of the ER is protected by a sepa-
rate unfolded protein response (UPRER) [39]. The most conserved
branch of the UPRER consists of the ER membrane spanning kinase
Ire1 and the bZip transcription factor Xbp1. Ire1 monitors the
protein-folding environment of the ER lumen and initiates URPER sig-
naling by directly recognizing unfolded proteins [40]. If stress occurs
in the ER, Ire1 oligomerizes [41] activating its cytosolic kinase do-
main. Once activated, the cytosolic domain of Ire1 splices an intron
from the Xbp1 transcript [42] allowing translation of a functional
bZip protein which trafﬁcs to the nucleus to induce the UPRER. The
UPRER includes a number of ER-targeted protein-folding machineries
including BiP, an ER-targeted Hsp70, protein disulﬁde isomerase and
the glycosylation machinery [43]. Additionally, the UPRER activates
expression of ERAD (ER-associated degradation) components which
serve to recognize misfolded proteins, retrotranslocate them across
the ER membrane to the cytosol where they are ubiquitylated and de-
graded by the proteasome [44].
In addition to increasing ER-speciﬁc protein folding and quality
control machinery, a branch of the UPRER also brieﬂy attenuates
protein translation to reduce the load on ER folding capacity [39].
In response to ER stress, the ER membrane spanning kinase PERK
(Pancreatic enriched ER kinase) dimerizes and phosphorylates the
alpha subunit of eIF2 (eukaryotic initiation factor), which serves to
attenuate protein translation [45].
Conceptually similar to the UPRER and heat shock response, accumu-
lating evidence supports the existence of a UPRmt; a mitochondria-to-
nucleus signal transduction pathway that senses unfolded protein
stress within the organelle and transmits a signal out of mitochondria,
through the cytosol to the nucleus where the up-regulation of genes
encoding mitochondrial chaperones and quality control proteases
takes place to re-establish mitochondrial protein homeostasis [5].
3. Retrograde transcriptional responses from mitochondria
suggested the presence of a UPRmt
The survival of cells devoid of mtDNA (ρ0 cells) suggested the ac-
tivation of nuclear responses as compensation for severe mitochon-
drial dysfunction. Indeed, ρ0 cells undergo a number of changes in
nuclear gene expression including the induction of mitochondrial
molecular chaperone and protease genes [46–49]. The absence of
mtDNA places a considerable amount of stress on the mitochondrial
protein-folding environment as those ETC components encoded by
the nucleus are still imported into mitochondria but unable to assem-
ble into stoichiometric complexes in the absence of their mtDNA-
encoded binding partners. In addition to increasing the mitochondrial
protein homeostasis machinery, cells down-regulate the expression
of the ETC components in complex I, III and IV to protect the
protein-folding environment but not the ATP synthase as it is
Fig. 1. Model of the mammalian UPRmt signaling pathway. Activation of the UPRmt in
mammalian cells occurs in response to stress originating from the mitochondrial ma-
trix or the intermembrane space (IMS), each having distinct signal transduction path-
ways and transcriptional responses. Accumulation of unfolded proteins within the
matrix stimulates the transcriptional up-regulation of the transcription factor CHOP
via JNK2 and c-Jun [57,62]. CHOP subsequently activates the transcription of genes in-
cluding the quality control protease ClpP and the chaperonin Hsp60 [58]. Alternatively,
accumulating unfolded proteins in the IMS causes activation of the kinase AKT and
phosphorylation of the estrogen receptor (ERα) leading to the transcriptional up-
regulation of the IMS protease Htra2 and the transcription factor NRF1 [64].
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ρ0 cells also down-regulate numerous components required for pro-
tein translation [49], consistent with slowed import reducing the
load on the mitochondrial protein-folding environment [50]. Interest-
ingly, the lack of mtDNA also affects the expression of a number of cell
cycle regulators such as p19, a cyclin dependent kinase inhibitor in-
volved in cell cycle arrest at G1 [46], suggesting that the cell cycle is
slowed during periods of mitochondrial dysfunction to prevent repli-
cation of cells with defective mitochondria.
Other forms of mitochondrial stress also elicit transcriptional pro-
grams consistent with the presence of a UPRmt. For example, deletion
of the yeast Paraplegin homolog Yta12, which encodes a mitochon-
drial quality control protease [4], results in mitochondrial protein ag-
gregation and widespread changes in nuclear-encoded genes [51,52].
Similarly, inhibition of mtHsp90 results in the up-regulation molecu-
lar chaperone genes as well as a number of genes involved in metab-
olism [53]. Together, these data suggest the presence of speciﬁc stress
response pathways that protect against mitochondrial dysfunction.
Perhaps the best-characterized mitochondria-to-nuclear signal
transduction pathway is the retrograde response (RTG), thoroughly
characterized in yeast. The RTG pathway is activated during mito-
chondrial dysfunction including that caused by mtDNA depletion to
increase activity of numerous metabolic pathways that compensate
for the lack of mitochondrial activity. For example, a peroxisomal iso-
form of citrate synthase (CIT2) is induced to increase activity of the
glyoxylate cycle, a variant of the tricarboxylic acid cycle induced in
ρ0 cells [54]. The RTG response is mediated by RTG1 and RTG3, two
basic helix-loop-helix leucine zipper (bHLH/Zip) transcription factors
[55,56]. When mitochondria are functional, RTG3 is hyperphosphory-
lated, sequestering both itself and RTG1 in the cytoplasm [56]. How-
ever, mitochondrial dysfunction causes RTG3 to be partially
dephosphorylated allowing nuclear translocation of the RTG1/3 com-
plex and the induction of the compensatory response.
While the RTG response is required for the induction of many
genes required for metabolic adaptations, it does not regulate the
expression of mitochondrial chaperone or protease genes during
mitochondrial stress, suggesting an independent mechanism for
UPRmt activation. Here, we review the emerging data regarding
the mechanisms of stress sensing and mitochondria-to-nucleus sig-
nal transduction.
4. Mitochondrial-to-nuclear UPRmt signal transduction in
mammalian cell culture
To demonstrate the presence of a UPRmt, a terminally misfolded,
mutant form of ornithine transcarbamylase (OTC) was targeted to
the mitochondrial matrix. The presence of unfolded protein in the
matrix resulted in the increased expression of several genes that pro-
mote mitochondrial protein homeostasis including Hsp60, Hsp10,
mtDnaJ and ClpP (Fig. 1) [57]. Importantly, expression of cytosolic
and ER chaperone genes were unaffected, indicating speciﬁcity of
the UPRmt. The promoters of the Hsp60, ClpP and mtDnaJ genes were
shown to contain a mitochondrial stress responsive element that cor-
responds to the CHOP (CCAAT/enhancer-binding protein (C/EBP)-ho-
mologous protein) transcription factor consensus binding site [57,58].
Additionally, the CHOP gene itself is up-regulated during mitochon-
drial stress, further supporting a central role for CHOP in UPRmt sig-
naling [57].
However, it was somewhat surprising that CHOP was shown to in-
duce a mitochondrial speciﬁc response considering that CHOP is also
known to be activated by ER stress, genotoxic stress, as well as arse-
nite exposure [59–61]. Interestingly, an AP-1 (activator protein-1) el-
ement within the CHOP promoter is necessary for mitochondrial
stress-induced expression [62]. The transcription factor c-Jun is
known to bind to the AP-1 consensus sequence upon activation by
JNK (c-Jun N-terminal kinase) [63], suggesting that c-jun and JNKplay a role upstream of CHOP in UPRmt signaling. Indeed, increased
mitochondrial unfolded protein stress stimulates the phosphorylation
of JNK2, providing further support for a role of this kinase in CHOP ac-
tivation [62] (Fig. 1). Numerous downstream regulatory events in
UPRmt signaling have been documented including transcription factor
activation and the resulting transcriptional outputs. However, several
questions still remain including the mechanism cells use to sense un-
folded proteins within the matrix and how the signal is transmitted
across both mitochondrial membranes. Additionally, does the re-
sponse, which has been studied in cell lines, occur in vivo and does
CHOP inhibition impair mitochondrial chaperone induction?
Recent ﬁndings have indicated the presence of a separate UPRmt
signaling pathway that speciﬁcally responds to unfolded protein
stress within the IMS (Fig. 1) [30,64]. Expression of mutant EndoG
that localizes to the IMS causes AKT phosphorylation and activation
of the nuclear hormone receptor estrogen receptor alpha (ERα)
[64], consequently resulting in the increased expression of the IMS-
localized quality control protease HtrA2 and the transcription factor
NRF1, which is involved in mitochondrial biogenesis [64]. UPRmt reg-
ulation by the estrogen receptor is consistent with its documented
role in promoting mitochondrial ﬁtness [65]. In addition to HtrA2, ac-
tivity of the proteasome is also increased in response to IMS stress
which is hypothesized to prevent the accumulation of misfolded
IMS proteins by ubiquitylating them prior to import [64]. The early
studies on the IMS-speciﬁc UPRmt provide a framework for signal
transduction but several similar questions to those of the matrix-
speciﬁc response remain to be addressed.
5. Mitochondrial-to-nuclear UPRmt signal transduction in
C. elegans
To identify additional UPRmt signaling components and dissect
the signaling mechanisms we established a genetically tractable
model system using C. elegans. Mitochondrial chaperone gene ex-
pression is monitored in vivo using UPRmt reporter worms which
harbor promoters of the mitochondrial chaperone genes Hsp60 or
mtHsp70 driving expression of GFP [52]. Similar to mammalian
cells, treatment of C. elegans with ethidium bromide, a chemical re-
agent known to reduce mtDNA transcription and replication [66],
causes increased expression of the mitochondrial chaperone re-
porters as well as endogenous mitochondrial chaperone genes
[52]. Additionally, knockdown of the mitochondrial quality control
protease SPG-7/Paraplegin and mitochondrial chaperone genes
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perturbations in the mitochondrial protein-folding environment ac-
tivate this transcriptional response.
Using the UPRmt reporter worms, we performed a genome-wide
RNAi-based screen to identify a number of components required for
UPRmt signal transduction that constitute a signaling pathway con-
necting the mitochondrial matrix to the nucleus [67–69]. The current
data suggest the following model for how stress is sensed in the mi-
tochondrial matrix and transmitted to the nucleus. As unfolded pro-
teins exceed the matrix chaperone capacity, they are degraded by a
quality control protease into peptides, which are pumped across the
inner membrane by a peptide transporter. Peptide efﬂux leads to
the activation of a bZip transcription factor, which accumulates in
the nucleus to activate mitochondrial chaperone gene induction
(Fig. 2) [5,69]. The data that support this model are described in the
following sections, however it should be noted that perturbations
that affect the mitochondrial protein-folding environment are likely
to also affect diverse aspects of mitochondrial biology and potentially
unidentiﬁed signaling mechanisms.
5.1. Initiation of UPRmt signaling
Knockdown of the mitochondrial quality control protease ClpP
abolishes induction of mitochondrial chaperone genes during mito-
chondrial stress [68], which has more recently been observed in
mammalian cells [70]. Consistent with a role in mitochondrial protec-
tion, worms with reduced ClpP activity develop much slower in the
presence of mitochondrial stress [68]. The localization of ClpP within
the mitochondrial matrix, the same compartment where the stress
originates, suggests an upstream function for the quality control pro-
tease in UPRmt signaling.
ClpP recognizes and degrades misfolded proteins into peptides of
approximately 8–20 residues [71]. Interestingly, peptides that accu-
mulate in the mitochondrial matrix are extruded into the IMS via an
ABC (ATP Binding Cassette) transporter; Mdl1 in yeast [72] and
HAF-1 in C.elegans [69] suggesting ClpP-derived peptides may act as
signaling components in the UPRmt. Indeed, deletion of the ATP-
dependent peptide transporter HAF-1 attenuates UPRmt activation
during mitochondrial stress [69]. HAF-1 is localized within theFig. 2. Model of the C. elegans UPRmt signaling pathway. UPRmt signaling is initiated as
unfolded proteins accumulate beyond the resident chaperone folding capacity. To pre-
vent protein aggregation, unfolded or misfolded proteins are degraded to peptides by
the quality control protease ClpP in the mitochondrial matrix [68]. HAF-1-mediated
peptide efﬂux leads to activation of the bZip transcription factor ATFS-1 that accumu-
lates in the nucleus. HAF-1-mediated peptide efﬂux is also required for the accumula-
tion of the ubiquitin-like protein UBL-5 which complexes with the transcription factor
DVE-1 [69]. ATFS-1 and DVE-1/UBL-5 then cooperatively induce the expression of mi-
tochondrial chaperone genes including Hsp60 and mtHsp70 in order to restore protein
homeostasis.mitochondrial inner membrane and is essential for survival under
conditions of protein misfolding [69] similar to ClpP. Additionally,
ATP-dependent efﬂux of peptides from mitochondria is reduced fol-
lowing loss of clpp-1 and haf-1, suggesting a role of ClpP upstream
of HAF-1 [69].
5.2. UPRmt signaling requires the transcription factor ATFS-1
The requirement for ClpP and HAF-1 suggests a means to sense
unfolded protein stress and transmit the signal to the cytoplasm,
however the downstream transcription factor was unknown. We re-
cently identiﬁed the bZip transcription factor ATFS-1 (Activating
Transcription Factor associated with Stress, previously known as
ZC376.7) as being required for UPRmt signaling and acting down-
stream of HAF-1 [69]. Similar to inhibition of ClpP and HAF-1,
worms lacking ATFS-1 develop much more slowly in the presence
of mitochondrial stress consistent with a role in mitochondrial pro-
tection. Furthermore, during mitochondrial stress, ATFS-1 accumu-
lates in the nucleus in a HAF-1-dependent manner, demonstrating
that matrix protein degradation and peptide efﬂux act upstream of
ATFS-1 [69]. The mechanism by which the efﬂux of mitochondrial-
derived peptides inﬂuences ATFS-1 remains to be determined. How-
ever, it is conceivable that the released peptides are recognized by
specialized receptors or perhaps the rate of peptide efﬂux determines
downstream activation of ATFS-1.
5.3. The UPRmt requires a second transcriptional complex consisting of
DVE-1 and UBL-5
The homeobox transcription factor DVE-1 and the ubiquitin-like
protein UBL-5 are also required for transcriptional up-regulation of
mitochondrial molecular chaperone genes [68]. DVE-1 is localized
within nuclei of all cells but undergoes a nuclear re-distribution
when the mitochondrial protein-folding environment is perturbed,
at which time it binds to the promoters of mitochondrial molecular
chaperone genes [68]. ClpP functions upstream of DVE-1 as ClpP inhi-
bition impairs the nuclear redistribution of DVE-1 during stress [68].
Interestingly, the transporter HAF-1 is unnecessary for DVE-1 nuclear
re-distribution [69], suggesting a separate means of activation. During
mitochondrial stress, ubl-5 expression is up-regulated in a DVE-1 and
HAF-1-dependent manner and forms a complex with DVE-1 that is
required for UPRmt activation [68]. Interestingly, we demonstrated
that the mammalian orthologs of DVE-1 and UBL-5 (SatB2 and
Ubl5) are also able to form a complex suggesting a similar role in
mammalian cells [68]. However, it has yet to be determined if SatB2
is required for UPRmt signaling in mammalian systems.
The current model of UPRmt signal transduction suggests similari-
ties and differences with the well-characterized UPRER (Section 2).
While both culminate in the transcriptional induction of
compartment-speciﬁc protein folding machinery by organelle-
responsive transcription factors, the means by which unfolded pro-
teins are detected and the signal transmitted to the respective tran-
scription factors are different. The different signaling mechanisms
appear to stem from differences in ER and mitochondrial architecture.
The luminal domain of the ER-localized membrane spanning kinase,
Ire1, directly senses unfolded proteins within the ER lumen [40] and
transmits the signal to the cytosolic domain of Ire1, which directly ac-
tivates the transcription factor Xbp1 [39]. Mitochondria have separate
stress responses that respond to perturbations in the matrix [52,57]
or IMS [64]. The current model for UPRmt signaling suggests that un-
folded or misfolded proteins are detected in the matrix by the quality
control protease ClpP, which degrades them to peptides. The peptides
are then pumped across the inner membrane leading to the activation
of ATFS-1 through an unknown mechanism [69]. As data emerges on
the variety of UPRmt signaling mechanisms it will be interesting to
compare and contrast them to the UPRER. For example, a separate
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protein-folding environment within the ER lumen when the load of
unfolded proteins exceeds the capacity of ER chaperones. A conceptu-
ally similar response has not been identiﬁed in the UPRmt despite
pharmacological inhibition of translation being protective against mi-
tochondrial dysfunction [50].
6. The relationship between the UPRmt and other mitochondrial
stress response pathways
Recent studies have indicated that severely damaged or energeti-
cally dead mitochondria are cleared from the cell via autophagic deg-
radation through a pathway known as mitophagy [73–75]. The kinase
PINK1 accumulates speciﬁcally on the outer membrane of mitochon-
dria in which the membrane potential has been completely dissipated
[76]. PINK1 then recruits Parkin and the downstream autophagy ma-
chinery that directs the defective organelles to lysosomes for degra-
dation [77]. Interestingly, similar stresses that ultimately result in
mitophagy also activate the UPRmt. For example, depletion of mito-
chondrial DNA, expression of mutant components of the ETC [78] as
well as exposure to paraquat strongly activate both the UPRmt as
well as the mitophagy pathway [74]. Because the UPRmt promotes
total cellular mitochondrial function by up-regulating protective
components to re-establish organellar homeostasis while mitophagy
eliminates severely defective or dead organelles, we hypothesize
that the UPRmt is activated prior to the mitophagy pathway. If the or-
ganelle cannot maintain a membrane potential despite UPRmt activa-
tion the defective organelle enters the mitophagy pathway (Fig. 3).
Ultimately, if mitochondrial damage becomes too pervasive, the cell
undergoes apoptosis. As data emerge on all three pathways, it will
be of interest to determine how the pathways integrate to protect mi-
tochondrial, cellular, tissue and ultimately organismal health.
7. Perspective: the UPRmt and the regulation of lifespan
The relationship between mitochondrial health and organismal
life span has been the focus of much attention in recent years with
numerous studies reporting a decline in mitochondrial function
with age [12]. Therefore it is somewhat surprising that in worms,Fig. 3. Proposed relationship between the UPRmt, mitophagy and apoptosis during mi-
tochondrial stress. Mitochondrial stress and dysfunction result in the activation of at
least three cellular responses including the UPRmt, mitophagy and apoptosis. We pro-
pose the depicted relationship between the three pathways as a function of mitochon-
drial stress level or the duration of mitochondrial stress. Because the UPRmt is a
mitochondrial protective response activated to re-establish homeostasis within
stressed organelles and mitophagy removes severely defective mitochondria with a
completely dissipated inner membrane potential, we propose the UPRmt is activated
at lower levels of stress or prior to the induction of mitophagy. As stress in individual
mitochondrion exceeds the cytoprotective capacity of the UPRmt, mitophagy eliminates
the dead organelles. However, if the total cellular mitochondrial damage becomes too
great the cell may undergo apoptosis.ﬂies and mice, mutations that cause ETC dysfunction extend lifespan
as much as 50% [79–82]. Many groups had hypothesized that the ex-
tension in lifespan was due to the activation of a cyto-protective com-
pensatory response. Recently, it has been shown that ETC mutations
that extend lifespan also activate the UPRmt [83]. Impressively, the
UPRmt was required for the lifespan extension observed in the ETC
mutants [83], supporting a role for the maintenance of the mitochon-
drial protein-folding environment in lifespan determination [6].
However, it has yet to be determined if HAF-1 or ATFS-1 are required
for lifespan extension in the ETC mutants.
While the UPRmt is necessary for lifespan extension, it has yet to
be determined if it is sufﬁcient. It will be interesting to determine if
UPRmt activation, perhaps by over-expression of ATFS-1, is capable
of extending lifespan independent of mitochondrial dysfunction. Ad-
ditional signaling pathways also contribute to the lifespan extension
of ETC mutants including CEH-23 [84] and Hif-1 [85] indicating that
multiple compensatory responses contribute to lifespan extension in
the ETC mutants.8. Perspective: the UPRmt in cancer therapeutics
Mounting evidence suggests that cancer cells are exposed to
higher levels of mitochondrial stress than normal cells, suggesting a
dependence on cellular pathways and components that protect the
mitochondrial protein-folding environment [86]. Cells within the
tumor interior are exposed to hypoxic conditions, which inhibit pro-
tein folding in the IMS and cause remodeling of mitochondrial struc-
ture and function [87]. Additionally, cancer cells accumulate mtDNA
mutations at relatively high rates [88] and mtDNA depletion has
been associated with cancer progression [89]. Similarly, reduced ex-
pression of mitochondrial ETC components, including those of com-
plexes I and III, have been observed in tumors [90–92]. While there
is little doubt that cancer cells incur greater mitochondrial damage
than normal cells, it is unclear whether the damage-associated alter-
ations in mitochondrial function provide an advantage or disadvan-
tage. Regardless, these observations suggest a role for the UPRmt to
protect cancer cell mitochondrial function.
For example, Hsp60 expression is increased in a number of can-
cers including tumors of the digestive, reproductive, nervous sys-
tems [93–96]. Elevated levels of Hsp60 likely promote efﬁcient
protein folding within the stressed folding environment, although
alternative functions of Hsp60 have also been suggested consistent
with forced overexpression of Hsp60 causing transformation of em-
bryonic ﬁbroblasts [96]. Hsp60 has been shown to prevent apoptosis
by stabilizing the anti-apoptotic protein survivin [95] as well as by
inhibiting the pro-apoptotic proteins Bax and Bak [97], although it
is unclear where in the cell this interaction occurs. Consistent with
a prominent role for Hsp60 in cancer cell survival, reducing Hsp60
levels by RNAi reduces the oncogenic properties of multiple tumor
cell lines while having minimal effects on normal cells [53,95], dem-
onstrating the attractiveness of this chaperone in cancer target drug
development.
Similarly, the Hsp90-related, mitochondrial localized TNF receptor-
associated protein-1 (TRAP-1) chaperone is also highly expressed in a
number of cancerous tissues [98]. Similar to Hsp60, TRAP-1 prevents
apoptotic cell death via an inhibitory interaction with the immunophi-
lin chaperone Cyclophilin D [99]. Recently, the compound Gamitrinib
was shown to speciﬁcally inhibit themitochondrial pool of Hsp90 chap-
erones and activate a UPRmt [53,100]. Interestingly, Gamitrinib treat-
ment results in the speciﬁc death of tumor cells, suggesting a role for
TRAP-1 in the function of cancer cell mitochondria. Gamitrinib-
activated treatment also caused increased sensitivity to apoptosis [53]
opening future possibilities for combined cancer therapies that target
the UPRmt and apoptotic pathways simultaneously as a means to en-
hance treatment.
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The UPRmt is the collective cellular response to increased levels of
mitochondrial unfolded or misfolded proteins through the increased
transcription of nuclear-encoded genes that act to promote mito-
chondrial protein folding. While models detailing the UPRmt signal
transduction pathways have been proposed (Figs. 1 and 2), many
unresolved questions remain. Of particular interest is how extruded
peptides from mitochondria activate the transcription factor ATFS-1.
In the yeast retrograde pathway, the phosphorylation state of the
transcription factor RTG3 determines its activity [56]. ATFS-1 has a
serine-rich domain suggesting it may be regulated in a similar man-
ner where mitochondrial peptide efﬂux may affect phosphorylation
of ATFS-1 to impact its nuclear localization, although a putative ki-
nase or phosphatase has not been identiﬁed. A second unresolved
issue is the relationship between the transcription factors DVE-1
and ATFS-1. While both transcription factors are required for stress-
induced expression of mtHsp70 and Hsp60, the contribution of each
is unclear. Conceivably, each regulates a subset of genes or alterna-
tively, both are required for the induction of every UPRmt gene. It
will be important to identify the entire transcriptional output of
each transcription factor and the promoter elements with which
ATFS-1 and DVE-1 interact. Evidence from mammalian systems indi-
cates that the DVE-1 ortholog, SatB2, acts as a more general regulator
of transcription as it binds throughout the genome to AT rich se-
quences functioning as a nuclear scaffolding to affect global chroma-
tin organization [101]. Potentially, DVE-1 is required for nuclear
remodeling allowing ATFS-1 to directly interact with the promoters
of the UPRmt genes.
Many components involved in UPRmt signaling have been identi-
ﬁed in mammalian systems as well. It will be important to understand
the degree of conservation between the two systems. ClpP is required
for both the worm and mammalian UPRmt but the component(s) that
connect ClpP to the downstream transcription factors are currently
unclear. The mammalian homologs of HAF-1 and ATFS-1 have yet to
be identiﬁed although CHOP is a potential ortholog of ATFS-1 as
both are bZip proteins. Additionally, the role of the mammalian
UPRmt has primarily been explored in cell culture. It will be interest-
ing to examine its role in vivo to address the role of mitochondrial
protective mechanisms in diseases associated with mitochondrial
dysfunction including neurodegeneration and cancer [31,32,53]. Fur-
ther dissection of the UPRmt pathway will yield a better understand-
ing of how cells cope with mitochondrial dysfunction and allow for
the discovery of new targets to modulate mitochondrial protein-
folding capacity to promote cell survival or death.
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